Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Well before Andy's famous "In the coming weeks" statement I was in at .004 but now Im at .01
Guess you are right. Im debating if I want to buy more to average down a little
Wow what a yawn fest. I remember when this board was jumping. I hope we get approval soon Im starting to loose patience LOL
How do you know insiders are not buying?
Yea if they do a reverse split. Im hoping for .50 on approval
This month is going to be interesting because of all the recent developments along with releasing of the Q4 report.
I blame the FDA not for all but most of biels problems. I work with the FDA everyday I tell you this. They suck and take FOREVER. Just google average review time for the denovo process and you will see the following over 500 + days and they are not legally required to update you on the process. Another example I put in an FOIA request for "All written communication between them and Biel since 2009" After 4 months I got a call telling me they found a document from 2003 and one from january of this year (which was the warning letter they just got). So let me get this straight. Biel has not communicated in writting to the FDA since 2003? How have they communicated, smoke signals? Take it from me it's all in the FDA hands and they will response when they are ready to respond.
Also what would be good for the pps if this happens would be to release the news in stages rather than all at once.
1. patch 1 approve
2. patch 2 approved
3. patch 3 approved
Yea that's what I was thinking which would be awesome if that is the case.
No update since last July? Wth. This CEO needs to burn.
Ha Ha. Dude I meant if you check all the post from yesterday this was the hot topic.
This is old news.
Honestly Kidnova the person(s) that wrote the warning letter probrably dont know anything about the Denovo apps LOL. FDA is one big black hole. I would love to see Andy's response letter.
Yep I noticed that too. I believe for the most part people are being more patient than normal because of the potential for huge gains (risk reward). could you image selling at a loss and then the company recieving FDA shortly thereafter? happened to me last year for a 250k mistake. Such a kick in the you know what.
I find a silver lining in everything. You have to use common sense and realize that some competitor or scorned investor reported this. Read the letter and you will realize that the FDA didnt say anything about the denovo apps only the information about the NSEs. I really think some punk basher reported this in an effort to make the stock drop. But thats me with my conspiracy theorys LOL
I believe we many drop but Im looking at it with a VERY Silver lining. I now have some concrete dates to go by.
That's fair. We can only guess based on what they said until the report comes out cause the truth is always in writing right (Enron anyone) LOL. I hope atleast those numbers are good but they prob not going to be great with all of the dilution.
honestly the American people will buy anything with a celebrity attached to it so I dont see a problem with selling it here. Heck look what Dr OZ dis for them
Guys and Gals
As most of you know I do clinical trials for a living and see this type of crap everyday. Delays upon Delays which is why I still remain positive about BIEL eventhough we dont have any cash. Here is a good read
http://blog.fdazilla.com/2011/04/fda-de-novo-process-101-for-medical-devices/
They may or may not. I believe a company will purchase them soon after approvals come in. Seen it a hundred times. AIMO
I guess depends on what you define as "Very Well". This seems to now be a slow bleed of which only Canada or FDA can stop.
The Q4 report is going to be interesting to say the least. Does anyone know when the applications where submitted to the FDA?
BioElectronics Investor Update – Thursday, February 16, 2012
Recent Updates – BioElectronics Corporation
European Health Care
BioElectronics Andrew Whelan and Patrick O’Leary, President of Greenwood Group, is attending the prestigious European Health Care, Vitamin, Diet & Nutrition Show in Monte Carlo on Feb. 21 -23. The event allows manufacturers of OTC products, such as BIEL, to present their products and programs to Eastern and Western European retailers and distributors from many nations representing numerous different potential sellers of these products. “Readers of our bi-monthly newsletter will note the trend. We attended a similar important conference recently representing a number of Arab nations and we also spoken in these updates about our efforts to garner shelf space and sales in Canada. We will soon be announcing that Shanghai Suokang Medical Implants Co. Ltd. will be distributing BIEL products in China, the world’s most populous nation. That very successful company has wide-ranging resources, including the ability to do extensive clinical trials. We are following through on our stated goal to make our products known and sold worldwide rather than simply waiting for approvals in the U.S.,” Mr. Whelan explained. “These kinds of conferences are vital in allowing us to present our products to many retailers in just a few days.”
Juno Pharmaceuticals
BioElectronics signed a Distribution Agreement with Juno Pharmaceuticals, headquartered in Hyderabad, India. Juno Pharmaceuticals (http://www.junopharm.com) is relatively new entity funded and supported by experienced Canadian and Indian private equity fund managers focused on global opportunities in sourcing, licensing and acquisition of pharmaceutical and medical devices. “I believe our purpose is clear. Ours will be an international company with sales throughout the globe by the very best distributors and retailers we can find,” Mr. Whelan stressed.
All newcomers
Here is some good DD from the yahoo crap board.
Looking for reasons to stop buying. These are the 20 reasons I continue to accumulate shares:
1) Could easily sell 5 million Biel products "overnight" upon FDA approval. Using $30 as the average sale price generates $150 mil in revenue. Using the 10 multiplier for rev/market cap (standard for new, high growth company - Facebook is expected to have a 15 multiplier) yields $1.5 billion market cap. Dividing $1.5 billion by 2.5 billion authorized shares yields .60/share.
2) Expecting sales/revenue to increase more than 10 fold (10 times) in fourth quarter compared to last quarter. Based on channel checks, sales should be at least $500k in the fourth quarter versus $43k in the third quarter. Could lead to first quarterly profit ever, which should get PPS into the pennies.
3) Great review on "Doctor Oz" recently, which led to $60k in sales in a day, more than the prior 4 months total.
4) Five pending FDA product approvals -Actipatch or Allay will make this skyrocket upon approval.
5) #1 seller on Amazon after the Dr Oz show.
6) Good review on "The Doctors" last year.
7) 2009 Wall Street Journal Innovation award winner.
8) Insiders own a large chunk of shares. Float remaining for the public may only be about 500 million shares.
9) Doctors have used PEMF in hospitals for decades to treat numerous ailments via huge machines. Biel owns the patents to the pocket sized patches which have the same effect.
10) The FDA has already approved Recovery RX to be safe and effective after eye surgery. It's only a matter of time that we get the other approvals.
11) Biel in its infancy, like Apple in its garage stage
12) Products that relieve pain should sell better than IPOD's
13) Everyone that has tried the product raves about how great it is (I concur, also see reviews on Amazon and Kosher)
14) Canada launch - 80,000 units pending shippment any day now.
15) Knee and Back actipatch #1 and #2 seller on koshervitamins.com for months after Dr. Oz show.
16) Reasonable to estimate 1000 knee and 1000 back actipatches sold on koshervitamins.com in 30 days after Dr. Oz, plus 1000 total for other actipatches (wrist, heel, etc.). Estimation of sales through Kosher (for 30 days); 3000 x $30 = $90k rev.
17) With FDA approval, Biel will have a virtual monopoly on the minaturized PEMF treatment market. Add the under $10 price (soon for 7 day battery product) and patent protection, and you have a monopoly (like Microsoft and Apple).
18) Potential $100 billion+ in the pain relief market.
19) Tax free profits for first $20 million due to tax loss carryforward
20) Share price being held down due to very few brokers you can buy shares through (Schwab, Etrade, Fidelity), and fact all brokers can sell (unfairly skewed market - oversupply of sell versus buy).
Perfect storm = quarterly profit, Canada and UK launch, FDA approval,US launch, DTC removal, exchange listing. This would get pps into the dollars per share.
People forget the reason it is taking so long is BIEL had to go though the 501k process to have it fail before moving to the denovo process and they took over a year to provide the benchmark results so we are nearing a decision soon based on my calculations. I miscalculated before when I failed to include the time it took them to provide the benchmark test. But hey NO ONE can tell when the FDA will make a decision as all they ever say is "We are reviewing your application".
From DDLS
DDLS calls me a pumper. Im sorry if I believe in the company.
Facts
1. Company has a product that works
2. Company diluting; Because they have to
3. FDA is the road block; FDA stated numerous times that they are late and they usually are.
Thats the plan. We should focus on getting FDA approval before worrying about getting uplisted. FDA approval and Canada lauch is #1
being down 45k I hope your right
cool, Why you buy at 27 you prob could have held out for 25
Nice one million share hit
Nice 1.1 million share buy
Yes dude,
They will pop. You know how many people are looking at this. Heck you looking at this and you don't like the company. On approval day we will hit .25-35 and the settle in at low 20s
Dude I could care less about sales. Once they get approval they WILL be brought. This is an FDA play.
-----Original Message-----
From: xxx [mailto:xxx]
Sent: Wednesday, February 08, 2012 11:21 AM
To: info@bielcorp.com
Subject: Total days
Hello
Can you tell me how many days have passed since all applications have been
submitted to the FDA?
RESPONSE:
Well no. And it is of no relevance. It would be like asking how many pages
were submitted. I'm not trying to be a wise guy but the FDA is going to
rule when the FDA is ready and not a moment sooner. I've had lots of
clients with lots of products and medical devices in front of the FDA and
the progress is almost always slow. The FDA says the matter is "under
review." That's all they'll tell you.
Paul Knopick
Niether is the bashing. Only affecting the pps is diluting which the company must do to weather the FDA delay
Yep I believe and so do you.
1) Great review on "Doctor Oz" recently, which led to $60k in sales in a day, more than the prior 4 months total.
2) Five pending FDA approvals- Actipatch or Allay will make this skyrocket upon approval.
3) #1 seller on Amazon after the Dr Oz show.
4) Good review on "The Doctors" last year.
5) Insiders own a large chunk of shares. Float remaining for the public may only be about 500 million shares.
6) Doctors have used PEMF in hospitals for decades to treat numerous ailments via huge machines. Bioelectronics owns the patents to the pocket sized disposable patches which have the same effect.
7) The FDA has already approved Recovery RX to be safe and effective after eye surgery. It's only a matter of time that we get the other approvals.
8) Word is just getting out about the stock and the products. Nobody knows about Biel except the shareholders (less than 200). Once the word gets out...
9) Biel in its infancy, like Apple in its garage stage
10) Products that relieve pain should sell better than IPOD's
11) Everyone that has tried the product raves about how great it is (check Amazon reviews, I concur)
12) 2009 Wall Street Journal Innovation award winner.
13) Canada launch: 80,000 units to be shipped any day now.
14) Once people become aware of Biel products, whether through improved Marketing, FDA approval or both, seems like selling 3 million of their products could happen "overnight". Using $33 as the average sale price generates $100 mil in fevs. Using the 10 multiplier for rev/market cap (standard for new, high growth company) yields $1 billion market cap. Dividing $1 billion by 2 billion authorized shares yields .50/share. Could easily sell 3 million products overnight with FDA approval and/or commencement of sales in stores in UK and/or Canada.
15) Knee and Back actipatch #1 and #2 seller on koshervitamins.com for months after Dr. Oz show.
16) Reasonable to estimate 1000 knee and 1000 back actipatches sold on koshervitamins.com in 30 days after Dr. Oz, plus 1000 total for other actipatches (wrist, heel, etc.). Estimation of sales through Kosher (for 30 days); 3000 x $30 = $90,000 revenue.
17) Expecting sales/revenue to increase more than 10 fold (10 times) in fourth quarter compared to last quarter. Based on channel checks, sales should be at least $500k in the fourth quarter versus $43k in the third quarter.
Simpsonly,
That's got to be the best response I have read on this board in a long time. Thanks and keep posting
LMBO. Man that was so funny but true.